News Focus
News Focus
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

Re: None

Thursday, 10/18/2007 1:31:03 AM

Thursday, October 18, 2007 1:31:03 AM

Post# of 3757
Thomas Ebeling, one of two NVS directors on IDIX’s BoD, has switched jobs from head of NVS’ pharma business to head of the consumer-health business. I think it’s fair to say he was demoted. (Source: NVS’ 3Q07 PR, which was issued minutes ago.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”